Bacterial Protoplast-Derived Nanovesicles Carrying CRISPR Cas9 Tools Efficiently Re-educate Tumor-Associated Macrophages for Cancer Immunotherapy
Ontology highlight
ABSTRACT: we developed an in vivo CRISPR-Cas9 genome editing system that targets tumor-associated macrophages (TAMs) via bacterial protoplast-derived nanovesicles (NVs) decorated with a pH-responsive PEG conjugated polymer and galactosamine-conjugated ligand
ORGANISM(S): Escherichia Coli Bl21(de3)
SUBMITTER: Junfeng Zhang
PROVIDER: PXD045507 | iProX | Wed Sep 20 00:00:00 BST 2023
REPOSITORIES: iProX
ACCESS DATA